Press Releases

News from the year: /2013

Business Update

Current contracted value signed in 2023 of £124 million, an increase of 47% compared to £85 million in the year ending 31 December 2022 (excluding COVID-19 vaccine manufacturing) On track…

Read more

2023 AGM Notification

London, UK – 5 May 2023: Oxford Biomedica plc (LSE:OXB) (“Oxford Biomedica”, “the Company” or “the Group”), a quality and innovation-led viral vector CDMO, gives notice that the Notice of Annual…

Read more

2022 Annual Report and Accounts

London, UK – 28 April 2023: Oxford Biomedica plc (LSE:OXB) (“Oxford Biomedica”, “the Company” or “the Group”), a quality and innovation-led viral vector CDMO, gives notice that the 2022 Annual report and…

Read more